The Centers for Medicare and Medicaid Services (CMS), in presenting
its preliminary physician fee schedule for 2005, is proposing cutting reimbursement
to physicians for administering several chemotherapy drugs.
CMS said the proposed changes are a result of implementation of the
Medicare Modernization Act of 2003. These changes are expected to save the
government $530 million during the upcoming fiscal year and $270 million during
the following year. Some have suggested the changes could reduce oncologist
practice revenue by between 2% and 8% annually.
Mitka M. Reimbursement for Cancer Drugs. JAMA. 2004;292(14):1673. doi:10.1001/jama.292.14.1673-d